-
- Australia
- Canada
- UK
- USA
- Afghanistan
- Albania
- Algeria
- American Samoa
- Andorra
- Angola
- Anguilla
- Antarctica
- Antigua and Barbuda
- Argentina
- Armenia
- Aruba
- Australia
- Austria
- Azerbaijan
- Bahamas
- Bahrain
- Bangladesh
- Barbados
- Belarus
- Belgium
- Belize
- Benin
- Bermuda
- Bhutan
- Bolivia
- Bosnia and Herzegovina
- Botswana
- Brazil
- British Indian Ocean Territory
- Brunei Darussalam
- Bulgaria
- Burkina Faso
- Burundi
- Cambodia
- Cameroon
- Canada
- Cape Verde
- Cayman
- Central African R
- Chad
- Chile
- China
- Cocos (Keeling)
- Colombia
- Comoros
- Congo, The DR
- Congo, Rep of
- Cook Is
- Costa Rica
- Cote d'Ivoire
- Croatia/Hrvatska
- Cuba
- Cyprus
- Czech Repu
- Denmark
- Djibouti
- Dominica
- Dominican R
- Timor-Leste
- Ecuador
- Egypt
- El Salvador
- Equatorial Guinea
- Eritrea
- Estonia
- Ethiopia
- Falklands (Malvinas)
- Fiji
- Finland
- France
- French Guiana
- French Polynesia
- French Southern Territories
- Gabon
- Gambia
- Georgia
- Germany
- Ghana
- Gibraltar
- Greece
- Greenland
- Grenada
- Guadeloupe
- Guam
- Guatemala
- Guernsey
- Guinea
- Guinea-Bissau
- Guyana
- Haiti
- Heard and McDonald Is
- Holy See (Vatican City State)
- Honduras
- Hong Kong
- Hungary
- Iceland
- India
- Indonesia
- Iran
- Iraq
- Ireland
- Isle of Man
- Israel
- Italy
- Jamaica
- Japan
- Jersey
- Jordan
- Kazakhstan
- Kenya
- Kiribati
- Korea, DPR
- Korea, Repub of
- Kuwait
- Kyrgyzstan
- Lao
- Latvia
- Lebanon
- Lesotho
- Liberia
- Libyan Arab Jamahiriya
- Liechtenstein
- Lithuania
- Luxembourg
- Montenegro
- Macau
- Macedonia
- Madagascar
- Malawi
- Malaysia
- Maldives
- Mali
- Malta
- Marshall Is
- Martinique
- Mauritania
- Mauritius
- Mayotte
- Mexico
- Micronesia, Federal State of
- Moldova
- Monaco
- Mongolia
- Montserrat
- Morocco
- Mozambique
- Myanmar
- Namibia
- Nauru
- Nepal
- Netherlands
- Netherlands Antilles
- New Caledonia
- New Zealand
- Nicaragua
- Niger
- Nigeria
- Niue
- Norway
- Oman
- Pakistan
- Palau
- Palestinian Territories
- Panama
- Papua New Guinea
- Paraguay
- Peru
- Philippines
- Pitcairn
- Poland
- Portugal
- Puerto Rico
- Qatar
- Reunion
- Romania
- Russian Federation
- Rwanda
- Serbia
- St Kitts and Nevis
- Snt Lucia
- Sa Vincent and the Grenadines
- San Marino
- Sao Tome and Principe
- Saudi Arabia
- Senegal
- Seychelles
- Sierra Leone
- Singapore
- Slovak R
- Slovenia
- Solomons
- Somalia
- South Africa
- South Georgia and the South Sandwich
- Spain
- Sri Lanka
- S Helena
- S Pierre and Miquelon
- Sudan
- Suriname
- Svalbard and Jan Mayen
- Swaziland
- Sweden
- Switzerland
- Syria
- Taiwan
- Tajikistan
- Tanzania
- Thailand
- Togo
- Tokelau
- Tonga
- Trinidad and Tobago
- Tunisia
- Turkey
- Turkmenistan
- Turks and Caicos
- Tuvalu
- Uganda
- Ukraine
- Unitd Arab Emirates
- UK
- USA
- Uruguay
- Uzbekistan
- Vanuatu
- Venezuela
- Vietnam
- Virgin Is, British
- Virgin Is, U.S.
- Wallis and Futuna
- Western Sahara
- Western Samoa
- Yemen
- Yugoslavia
- Zambia
- Zimbabwe
- Gift certificates
- Academic eBooks
- My account
- Help
- Wishlist
- Feedback
- Sign up
The Leading eBooks Store Online
for Kindle Fire, Apple, Android, Nook, Kobo, PC, Mac, Sony Reader...
Novel Developments in Stem Cell Mobilization
US$ 169.99
(+ tax)
Preview (read now)
Add to my own site
Give this ebook to a friend
Add to my wishlist
Author's page
Publisher's page
Devices
- iPad
- PC
- e-readers with Adobe Digital Editions installed
- Mac
See the full list
Available Devices
X
This book is available for the following devices:
- iPad
- Windows
- Mac
- Sony Reader
- Cool-er Reader
- Nook
- Kobo Reader
- iRiver Story
File Formats
Download: secure PDF.
You can also read this book online in eb20 format without having to download anything.
You can also read this book online in eb20 format without having to download anything.
Permissions
Printing
Copy/Paste
Read Aloud
Printing
Copy/Paste
Read Aloud
more
Recently the CXCR4/CXCL12-axis has been recognized as one of the pivotal adhesion pathways by which hematopoietic stem cells are retained in the bone marrow. CXCR4 antagonists with different chemical specification are being developed. Pharmacology research guides the way to the rational development effective antagonists. One antagonist, plerixafor, is clinically approved now for stem cell mobilization of lymphoma and myeloma patients. This allows patients to receive potentially life-saving treatment which could not have been administered otherwise. Through early clinical studies it was recognized that CXCR4 antagonists also mobilize malignant hematopoetic cells, i.e. leukemia cells. In preclinical studies a sensitization of mobilized leukemic cells to standard cytotoxic chemotherapy could be shown. Clinical studies are under way. CXCR4 antagonists are an exciting new class of compounds which are also employed for the mobilization of angiogenic cells or for the treatment of solid tumors. In this book a concise review of the current status of knowledge and future developments will be presented.
less
Subject categories
ISBNs
1461419603
9781461419594
9781461419600